Clinical Trial Update: A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating two standard doses of bevacizumab in combination with chemotherapy for epithelial ovarian cancer, including platinum-resistant dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Platinum-resistant Ovarian Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Ovarian Cancer, Platinum-resistant Ovarian Cancer | Phase 2 | Status: RECRUITING